Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 3/20 | 0.58 |
| ▸ | CPT2 | P23786 | 2/20 | 0.58 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HMGCR | P04035 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL59972 | 1.00 | ACLY (0.58) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL1409965 | 1.00 | ACLY (0.58) | ACLYCPT2HSPD1BLMHSPE1 | |
| Cadaverine Tartrate SCHEMBL9398238 | 0.89 | ACLY (0.59) | ACLYCPT2HSPD1BLMHSPE1 | |
| Malic Acid SCHEMBL29107079 | 0.84 | SMN1; SMN2 (0.54) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL13176929 | 0.83 | CPT2 (0.40) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL18283302 | 0.83 | ACLY (0.61) | ACLYCPT2HSPD1BLMHSPE1 | |
| Leucine SCHEMBL935696 | 0.82 | SLC7A5 (0.60) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL17632510 | 0.82 | ACLY (0.50) | ACLYCPT2HSPD1BLMHSPE1 | |
| Leucine SCHEMBL935695 | 0.82 | SLC7A5 (0.60) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL18283331 | 0.81 | CPT2 (0.39) | ACLYCPT2HSPD1BLMHSPE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110250660-A1 | METHOD FOR PRODUCING ALDEHYDE FROM CO2 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-10-13 | — | — | US | disclosed |
| US-20110201083-A1 | PRODUCTION OF C5-C8 ALCOHOLS USING EVOLVED ENZYMES AND METABOLICALLY ENGINEERED MICROORGANISMS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-08-18 | — | — | US | disclosed |
| EP-2346991-A2 | PRODUCTION OF C5-C8 ALCOHOLS USING EVOLVED ENZYMES AND METABOLICALLY ENGINEERED MICROORGANISMS | The Regents Of The University Of California (US) | 2011-07-27 | — | — | EP | disclosed |
| WO-2011088425-A2 | ELECTRO-AUTOTROPHIC SYNTHESIS OF HIGHER ALCOHOLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-07-21 | — | — | WO | disclosed |
| WO-2011037598-A1 | CONVERSION OF CO2 TO HIGHER ALCOHOLS USING RECOMBINANT PHOTOSYNTHETIC MICROORGANISMS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110201083-A1 | PRODUCTION OF C5-C8 ALCOHOLS USING EVOLVED ENZYMES AND METABOLICALLY ENGINEERED MICROORGANISMS | ADH5, ADH1C, ADH1A | ACLY 1169/4885CPT2 416/4885HSPD1 2653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.